Clinical Trial Update: Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining changes in endothelial function and biomarkers in African Americans with metabolic syndrome, focusing on hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Metabolic Syndrome

Snippet

Sponsor: InVasc Therapeutics, Inc. | Conditions: Hypertension | Phase 4 | Status: UNKNOWN